HugoScore hugoscore.org

Symptom assessment AI

aidoctorscan

aidoctorscan offers photo-based guidance about visible symptoms. Its public explanation distinguishes confidence from disease probability, but disclosure conflicts and limited model transparency make informed control difficult to assess. The profile is Mixed and unscored.

AI-assisted draft Read full report Open directory

Public-source review authorized for publication by Hugo Campos. No comprehensive human verification or generated-result testing.

Unscored Current comparison
Agency posture Mixed
The question we ask Who does aidoctorscan serve in this deployment?
Control Public English-language photo symptom checker and its information, pricing and policy pages. No photo analysis, paid report or authenticated workflow was tested.
Agency read Mixed
Vendor
ASTRAFLARE LIMITED, Hong Kong (identified by the service)
Who it serves
Patient-directed use of a vendor-controlled consumer assessment service
Primary User
People seeking first-step guidance about visible symptoms
Control Model
Vendor-hosted, with an unnamed external AI provider described on the homepage
Patient Impact
Suggested urgency and interpretation can influence whether and when a person chooses self-care or professional assessment.
Profile Status
AI-assisted draft
Last assessed
Sep 17, 2026
Review Confidence
Medium for public disclosures, low for implementation and outcomes (AI-assisted draft)
AI / Model
OpenAI Codex / GPT-6
Human Review
Hugo Campos authorized review, push and deployment. No comprehensive human verification is claimed.

Summary judgment · Unscored in current comparisons

Documentary review of a consumer workflow. Practical user control and behavioral effects remain untested.

Mixed

Useful uncertainty explanations coexist with conflicting privacy and access statements and unresolved correction mechanisms. No numerical agency ranking is assigned.

Patient agency

How this tool changes agency

Expands agency when

Could help people understand uncertainty, formulate questions and consider a next step.

Limits agency when

Users cannot readily reconcile the published data conditions or independently evaluate the basis of an urgency label. Real-world performance and correction mechanisms remain untested.

Patient agency assessment

Who sets and changes the goal?

Partial

People initiate the concern, but control of the assumptions behind an urgency label is not established.

Can patients tell AI is involved?

Yes

AI involvement is prominent. The model and version are not disclosed in the reviewed material.

Can patients meaningfully choose?

Partial

Conflicting account and storage statements complicate an informed decision before sharing a photo.

Can patients correct or challenge the output?

Not established

A personal-data correction right does not establish a route to challenge the assessment or obtain a corrected report.

Does it help patients understand or act?

Potentially

The described workflow offers next steps and optional visit preparation. No generated result or clinical outcome was evaluated.

Can patients evaluate the conditions of use?

Partial

The detailed confidence explanation is useful, but calibration, data handling and provider identity remain unresolved.

Text findings

What happens to patient data?

Partial and conflicting

Photo retention statements disagree. AI-provider handling, training use and deletion completion are not settled by the reviewed documents. Analytics are disclosed, but their receipt of health content was not established.

Who is left out or burdened?

Not independently evaluated

Camera quality, skin tone, language comprehension, digital access and paid detail may affect benefit. Accessibility and subgroup performance were not tested.

Are the clinical boundaries clear?

Partial

The service acknowledges that serious conditions can be missed. Its disclaimers and urgency guidance were reviewed, but their operation and comprehension in a generated result were not tested.

Who defined what good looks like?

Not disclosed

Patient authority over evaluation, independent clinical oversight and an appeals process were not established in the reviewed sources.

Review provenance

Criteria

CAIHL-derived HugoScore framework and current qualitative review method

Reviewer

AI-assisted public-source review prepared in OpenAI Codex

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized review, push and deployment. No comprehensive human verification is claimed.

Review date

2026-09-17

Limitations

No account creation, image upload, health-data transmission, purchase, generated-result testing, network inspection, security audit, clinical evaluation, legal determination or vendor correspondence. Sources accessed September 18 UTC, September 17 in America/Los_Angeles.

Review method

CAIHL public-source review with live rendered-page inspection and a bounded product-validation search. No account creation, health-data upload, purchase, result-generation test, security audit or clinical evaluation.

AI-assisted draft · Medium for public disclosures, low for implementation and outcomes (AI-assisted draft)